<!doctype html>
<html lang="en">
<head>
    <meta charset="utf-8"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <title>GENOME PROGRAM (PKGenP)</title>
    <meta
            name="description"
            content="Establishing a Library of Sequenced Genomes. A strategy for the future of Pakistan‚Äôs Health Care and Industrial Infrastructure"
    />
    <link rel="stylesheet" href="assets/styles.css"/>
    <script src="assets/style-variants.js"></script>
</head>
<body>
<div class="gov-container announce">
    <div class="logo">
        <img src="assets/images/precision-omics-icon-default.png" alt="Precision Omics Logo" class="logo-img"/>
    </div>
    <div class="gov">
        <img src="assets/images/gov_image.png" alt="Government of Pakistan" class="gov-img"/>
        <div class="text-container">
            <span>Government of Pakistan</span>
            <span>Ministry of National Health Services</span>
        </div>
    </div>
</div>
<header>
    <div class="container nav">
        <nav class="site-nav"><a href="index.html" aria-current="page">Home</a><a href="program.html">Program</a><a href="team.html">Team</a><a href="news.html">News</a><a
                href="#contact">Contact</a></nav>
        <a class="btn btn-ghost" href="#contact">Initiate Partnership</a></div>
</header>
<section class="hero">
    <div class="container hero-grid">
        <div class="reveal">

            <span class="pill">NATIONAL INITIATIVE</span>
            <span class="pill">VISION 2030</span>
            <h1>PAKISTAN</h1>
            <h2>GENOME PROGRAM (PKGenP)</h2>
            <div class="hero-info">
                <h3>A Globally Recognized National Asset for Pakistan</h3>
                <span>Establishing a Library of Sequenced Genomes. A strategy for the future of Pakistan‚Äôs Health Care and
                    Industrial Infrastructure</span>
            </div>


            <div class="logo-container"><span>Presented By </span>
                <img src="assets/images/precision-omics-icon-default.png" alt="Precision Omics Logo"
                     class="logo-img"/>
            </div>

            <div class="cta-row"><a class="btn btn-primary" href="#contact">Initiate Partnership</a><a
                    class="btn btn-ghost" href="news.html">Call to Action</a></div>
        </div>
        <div class="card reveal">
            <h3>Program Overview</h3>
            <p>A transformative national initiative to establish a genomics ecosystem that improves disease prevention, diagnosis, and treatment equity across Pakistan along with establishment of independent Governance & Ethics Board comprising of internationally recognized life Science leader for oversight.</p>
            <div class="program-projects">
                <div class="project-item">
                    <span class="project-icon">üß¨</span>
                    <h4>Cancer Genome Project</h4>
                </div>
                <div class="project-item">
                    <span class="project-icon">üéØ</span>
                    <h4>Priorities other unmet need Projects</h4>
                </div>
                <div class="project-item">
                    <span class="project-icon">üåç</span>
                    <h4>Large Scale Global Access Eurasian Research Library Project</h4>
                </div>
                <div class="project-item">
                    <span class="project-icon">üíä</span>
                    <h4>Drug Discovery Enterprise Project</h4>
                </div>
                <div class="project-item">
                    <span class="project-icon">ü§ù</span>
                    <h4>Pharma and Biotech Engagement Project</h4>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="about">
    <div class="container">
        <div class="section-title reveal"><h2>About</h2>
            <p>Company Profile</p></div>
        <div class="split">
            <div class="card reveal">
                <p><span class="bold">Precision Omics</span> is a joint venture between <span class="bold">LydiaRx, Premium Labs and Apha Digital Health, </span>established
                    to transform Pakistan‚Äôs Healthcare system by introducing precision medicine and multi-omics
                    diagnostics technologies that analyze a patient‚Äôs unique genetic and molecular profile to deliver
                    personalized diagnosis and treatment.</p>
                <p><span class="bold">LydiaRx</span> is a Swiss based venture studio building AI-Native, regulatory compliant by design solution
                    that transform pharma, biotech, life sciences R&D. The LydiaRx leadership team have over 100 years
                    of collective industry experience across a multi of Global organizations, focused on Genomics.</p>
                <p><span class="bold">Premium Lab (Pakistan) Pvt Ltd</span> is a leading healthcare provider with a history of delivering
                    healthcare services for nine years. Accredited by the Islamabad health regulatory authority, The
                    Company has earned the president of Pakistan award in 2022, Its vision is to empower better health
                    through diagnostics insight, aiming to become the most reliable healthcare services provider in
                    region.</p>
                <p><span class="bold">Alpha Digital Health</span> is global leader in health technology innovation enabling the future of
                    healthcare through cutting edge research, advance digital infrastructure, and confidential high
                    impact solution that balance national priorities with clinical excellence.</p></div>
            <div class="media-card reveal" style="min-height: 360px;"><img
                    src="assets/images/10000001000003CA000002862F9CA95221529DFB.png"
                    alt="Precision Omics presentation visual"
            /></div>
        </div>
        <div class="section-title reveal" style="margin-top: var(--section-pad);"><h2>Mission Statement</h2></div>
        <div class="mission-vision-grid">
            <div class="card reveal">
                <div class="tag">OUR VISION</div>
                <p>A healthier Pakistan powered by <span class="highlight">genomics</span>, delivering <span
                        class="highlight">equitable, data-driven precision healthcare</span> for every citizen.</p>
            </div>
            <div class="card reveal">
                <div class="tag">OUR MISSION</div>
                <ul>
                    <li><span class="highlight">Genetic Profiling</span> of local Population</li>
                    <li><span class="highlight">Early Detection</span> of Cancer</li>
                    <li><span class="highlight">Improve</span> Patients Health</li>
                    <li><span class="highlight">Increase</span> the Survival Rate</li>
                    <li><span class="highlight">Reduce</span> Treatment Cost</li>
                    <li><span class="highlight">Local Manufacturing</span> of Medicine</li>
                </ul>

            </div>

            <div class="card reveal">
                <div class="tag">Benefits for Pakistan</div>
                <ul>
                    <li>Set Pakistan up to become a future <span class="highlight">Regional Powerhouse</span> for Drug
                        discovery
                    </li>
                    <li>Improve on <span class="highlight">National Health Priorities</span> (especially Cancer
                        Targets)
                    </li>
                    <li>Building leading edge <span class="highlight">High Tech Genomics AI based Infrastructure</span>
                    </li>
                    <li>Create and Develop <span class="highlight">high skill jobs</span> and attract <span
                            class="highlight">Global Investments</span></li>
                    <li>Make a <span class="highlight">Global Center for Research & Clinical Trials</span> by
                        strengthening of domestic scientific and Clinical Capabilities
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>
<section id="cancer-burden">
    <div class="container">
        <div class="section-title reveal"><h2>Cancer Burden in Pakistan</h2>
            <p>Annual Report Data Updated 2025-2026</p></div>
        <div class="stats-grid">
            <div class="stat-card reveal">
                <div class="stat-number">185,748</div>
                <div class="stat-label">NEW CASES (ANNUALLY)</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">125,000+</div>
                <div class="stat-label">ANNUAL MORTALITY</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">105.6 / 100k</div>
                <div class="stat-label">INCIDENCE RATE</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">69.8 / 100k</div>
                <div class="stat-label">MORTALITY RATE</div>
            </div>
        </div>
        <div class="burden-analysis">
            <div class="card reveal">
                <h4>Key Challenges</h4>
                <ul>
                    <li><span class="highlight">High case fatality ratio</span></li>
                    <li><span class="highlight">Rising Trend</span></li>
                    <li><span class="highlight">500,000+</span> Existing Prevalence (Active Cases)</li>
                    <li><span class="highlight">75%+</span> LATE STAGE (III/IV) - Major barrier to curative treatment</li>
                </ul>
            </div>
            <div class="card reveal">
                <h4>Diagnostic Stage Distribution</h4>
                <p>Percentage of patients diagnosed at advanced stages</p>
                <p>Comparative rates per 100,000 population</p>
                <p><em>Sources: IARC GLOBOCAN 2024</em></p>
            </div>
        </div>
    </div>
</section>
<section id="why-patients-suffer">
    <div class="container">
        <div class="section-title reveal"><h2>Why Cancer Patients Suffer in Pakistan</h2>
            <p>Local Healthcare Limitations</p></div>
        <div class="card reveal">
            <h3>Diagnostic Challenges in Pakistan</h3>
            <div class="stats-grid">
                <div class="stat-card reveal">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">LATE STAGE DIAGNOSIS</div>
                </div>
                <div class="stat-card reveal">
                    <div class="stat-number">75%+</div>
                    <div class="stat-label">STAGE III/IV</div>
                </div>
            </div>
            <div class="challenge-analysis">
                <div class="challenge-card reveal">
                    <h4>Late-Stage Diagnosis</h4>
                    <p>Due to lack of screening and awareness, 60-70% of cancer patients are diagnosed at Stage III or IV, drastically reducing survival rates.</p>
                </div>
                <div class="challenge-card reveal">
                    <h4>Major Drop-off</h4>
                    <p>Only a fraction of patients get precision care due to limited infrastructure and expertise.</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="current-treatment">
    <div class="container">
        <div class="section-title reveal"><h2>Current Treatment Landscape</h2>
            <p>Public Sector Focus - PAEC & Tertiary Care</p></div>
        <div class="treatment-overview">
            <div class="card reveal">
                <h3>INFRASTRUCTURE, MODALITIES & CAPABILITIES</h3>
                <div class="stats-grid">
                    <div class="stat-card reveal">
                        <div class="stat-number">40,000+</div>
                        <div class="stat-label">NEW PATIENTS / YEAR</div>
                    </div>
                    <div class="stat-card reveal">
                        <div class="stat-number">19+</div>
                        <div class="stat-label">CANCER HOSPITALS</div>
                    </div>
                </div>
                <div class="treatment-details">
                    <h4>National Backbone</h4>
                    <p>Pakistan Atomic Energy Commission (PAEC) manages the majority of cancer treatment facilities with subsidized care and nuclear medicine focus.</p>
                    <h4>Available Modalities</h4>
                    <ul>
                        <li>Surgery</li>
                        <li>Chemotherapy</li>
                        <li>Radiotherapy</li>
                        <li>Limited Precision Medicine</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class="limitations-grid">
            <div class="limitation-card reveal">
                <h4>SHORTAGE</h4>
                <p>Only 21.4% of patients can access radiotherapy facilities despite over 60% requiring it, creating massive backlogs and treatment delays.</p>
            </div>
            <div class="limitation-card reveal">
                <h4>Precision Constraints</h4>
                <p>Limited access to molecular diagnostics and targeted therapies, resulting in suboptimal treatment outcomes.</p>
            </div>
        </div>
    </div>
</section>
<section id="precision-medicine">
    <div class="container">
        <div class="section-title reveal"><h2>What Is Precision Medicine?</h2>
            <p>Strategic Concept - Molecular Oncology</p></div>
        <div class="paradigm-shift">
            <div class="approach-card reveal">
                <h4>Traditional Approach</h4>
                <div class="approach-visual">
                    <div class="drug-box">Drug A</div>
                    <div class="patients-group">
                        <div class="patient responder">Responders</div>
                        <div class="patient non-responder">Non-Responders</div>
                        <div class="patient toxic">Toxic Effects</div>
                    </div>
                </div>
                <p class="approach-desc">"ONE SIZE FITS ALL" - Treatment is based on the organ of origin (e.g., Lung Cancer), regardless of underlying biology.</p>
            </div>
            <div class="approach-card reveal">
                <h4>Precision Medicine</h4>
                <div class="approach-visual">
                    <div class="biomarker-groups">
                        <div class="biomarker-group">
                            <div class="drug-box">Drug B</div>
                            <div class="patient-group">Patients Grouped by Biomarkers</div>
                        </div>
                        <div class="biomarker-group">
                            <div class="drug-box">Drug C</div>
                        </div>
                    </div>
                </div>
                <p class="approach-desc">"Treatment targets the specific molecular driver (e.g., EGFR mutation), maximizing efficacy."</p>
            </div>
        </div>
        <div class="workflow-section">
            <div class="card reveal">
                <h4>WORKFLOW THE PRECISION OMICS CYCLE</h4>
                <div class="workflow-steps">
                    <div class="step">
                        <div class="step-number">1</div>
                        <div class="step-text">Biopsy<br><small>Sample Collection</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">2</div>
                        <div class="step-text">WGS / Omics<br><small>Genomic Profiling</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">3</div>
                        <div class="step-text">Bioinformatics<br><small>Data Analysis</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">4</div>
                        <div class="step-text">Tumor Board<br><small>Expert Review</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">5</div>
                        <div class="step-text">Intervention<br><small>Targeted Therapy / Trial</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">6</div>
                        <div class="step-text">Outcomes<br><small>Tracking & Adjustment</small></div>
                    </div>
                </div>
                <p class="strategic-goal"><strong>Strategic Goal:</strong> Integrate this workflow into Pakistan's national cancer care network.</p>
            </div>
        </div>
    </div>
</section>
<section id="global-revolution">
    <div class="container">
        <div class="section-title reveal"><h2>Global Precision Medicine Revolution</h2>
            <p>From Reactive to Proactive Healthcare</p></div>
        <div class="card reveal">
            <h3>Paradigm Shift</h3>
            <p>Moving away from "one-size-fits-all" medicine to a proactive, data-driven approach where prevention and early detection take precedence over late-stage reaction.</p>
            <div class="workflow-visual">
                <div class="workflow-step">
                    <span class="step-number">1</span>
                    <h4>Sequence</h4>
                    <p>Genomic analysis</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">2</span>
                    <h4>Analyze</h4>
                    <p>Bioinformatics</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">3</span>
                    <h4>Diagnose</h4>
                    <p>Molecular profiling</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">4</span>
                    <h4>Treat</h4>
                    <p>Precision therapy</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">5</span>
                    <h4>Monitor</h4>
                    <p>Track response</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="success-stories">
    <div class="container">
        <div class="section-title reveal"><h2>Global Success Stories</h2>
            <p>International Case Studies & Lessons Learned</p></div>
        <div class="success-stories-grid">
            <div class="success-card reveal">
                <h3>The UK 100,000 Genomes Project</h3>
                <div class="success-stats">
                    <div class="success-stat">
                        <span class="stat-number">100,000</span>
                        <span class="stat-label">Genomes Sequenced</span>
                    </div>
                </div>
                <p>Established by Genomics England, this landmark initiative sequenced 100,000 whole genomes from NHS patients with rare diseases and common cancers. It successfully integrated genomic medicine into routine healthcare.</p>
                <div class="case-study">
                    <h4>Case Study: Rare Disease Impact</h4>
                    <p>THE CHALLENGE: Patients with undiagnosed rare diseases spent years navigating diagnostic odysseys.</p>
                    <p>THE RESULT: 25% of previously undiagnosed patients received definitive diagnoses through WGS.</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="national-programs">
    <div class="container">
        <div class="section-title reveal"><h2>Other National Genome Programs</h2>
            <p>Global Initiatives & Lessons Learned</p></div>
        <div class="programs-grid">
            <div class="program-card reveal">
                <h3>China: Precision Medicine Initiative</h3>
                <div class="program-stats">
                    <div class="program-stat">
                        <span class="stat-number">$9B</span>
                        <span class="stat-label">Investment</span>
                    </div>
                </div>
                <p>A massive $9B investment focusing on large-scale cohort studies and oncology. It integrates big data with clinical care to accelerate pharmaceutical innovation.</p>
            </div>
            <div class="program-card reveal">
                <h3>UAE: National Genome Program</h3>
                <div class="program-stats">
                    <div class="program-stat">
                        <span class="stat-number">Regional</span>
                        <span class="stat-label">Leader</span>
                    </div>
                </div>
                <p>Establishing comprehensive genomic infrastructure to become a regional leader in precision medicine and genomics research.</p>
            </div>
        </div>
    </div>
</section>
<section id="wgs-role">
    <div class="container">
        <div class="section-title reveal"><h2>Role of Whole Genome Sequencing (WGS)</h2>
            <p>Technology Overview - 100% Genomic Coverage</p></div>
        <div class="card reveal">
            <h3>THE GOLD STANDARD FOR COMPREHENSIVE GENOMIC PROFILING</h3>
            <div class="wgs-comparison">
                <div class="wgs-item">
                    <div class="wgs-coverage">
                        <span class="coverage-percent">100%</span>
                        <span class="coverage-label">of the Genome</span>
                    </div>
                    <div class="wgs-details">
                        <h4>Whole Genome Sequencing</h4>
                        <p>~3 Billion bp</p>
                        <p><strong>150,000+</strong> Actionable Mutations</p>
                    </div>
                </div>
                <div class="wgs-item">
                    <div class="wgs-coverage">
                        <span class="coverage-percent">&lt; 1%</span>
                        <span class="coverage-label">of the Genome</span>
                    </div>
                    <div class="wgs-details">
                        <h4>Targeted Panels</h4>
                        <p>~1-2 Million bp</p>
                        <p>Limited mutation detection</p>
                    </div>
                </div>
            </div>
            <div class="clinical-benefit">
                <h4>CLINICAL BENEFIT</h4>
                <div class="benefit-stat">
                    <span class="stat-number">24%</span>
                    <span class="stat-label">Proven Clinical Utility in Pediatric Cancers (Nature Medicine, 2024)</span>
                </div>
            </div>
        </div>
        <div class="advantages-grid">
            <div class="card reveal">
                <h4>Strategic Advantages for Pakistan</h4>
                <div class="advantage-item">
                    <span class="advantage-icon">üéØ</span>
                    <div>
                        <h5>Actionable Mutations</h5>
                        <p>Identifies rare driver mutations linked to approved targeted therapies often missed by panels.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üõ°Ô∏è</span>
                    <div>
                        <h5>Resistance Mechanisms</h5>
                        <p>Detects secondary mutations (e.g., EGFR T790M) to guide second-line therapy choices.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üë®‚Äçüë©‚Äçüëß‚Äçüë¶</span>
                    <div>
                        <h5>Hereditary Risk</h5>
                        <p>Simultaneous analysis of germline DNA to identify familial cancer syndromes for prevention.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üî¨</span>
                    <div>
                        <h5>Clinical Trial Access</h5>
                        <p>Matches patients to global clinical trials based on comprehensive molecular profiling.</p>
                    </div>
                </div>
            </div>
        </div>
        <div class="quote-card reveal">
            <blockquote>
                "Panel testing is like looking through a keyhole; WGS opens the entire door, ensuring no therapeutic opportunity is missed for Pakistani patients."
            </blockquote>
            <p><em>Sources: Nature Medicine (2024); ASCO Precision Oncology (2025); eCancer (2024)</em></p>
        </div>
    </div>
</section>
<section id="expected-outcomes">
    <div class="container">
        <div class="section-title reveal"><h2>Expected Outcomes & Impact</h2>
            <p>Project ROI - Multi-Dimensional Value</p></div>
        <div class="card reveal">
            <h3>TRANSFORMING HEALTHCARE DELIVERY & ECONOMY</h3>
            <p>The establishment of the Center and the 150,000+ WGS initiative will deliver measurable benefits across five strategic pillars, positioning Pakistan as a pioneer in the genomic era.</p>
        </div>
        <div class="outcomes-grid">
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üè•</span>
                    <h4>PATIENT CARE</h4>
                </div>
                <ul>
                    <li><strong>Higher Survival Rates:</strong> Targeted therapies significantly extend progression-free survival</li>
                    <li><strong>Reduced Toxicity:</strong> Avoiding "carpet-bombing" chemo preserves patient immunity</li>
                    <li><strong>Faster Treatment:</strong> Reduced "trial-and-error" prescribing cycles</li>
                </ul>
            </div>
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üí∞</span>
                    <h4>EFFICIENCY</h4>
                </div>
                <ul>
                    <li><strong>Avoid Futile Care:</strong> Stop paying for expensive drugs that won't work genetically</li>
                    <li><strong>Resource Optimization:</strong> Reduced hospital stays due to fewer adverse events</li>
                    <li><strong>Cost Savings:</strong> Long-term reduction in the national cancer burden</li>
                </ul>
            </div>
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üåç</span>
                    <h4>POPULATION</h4>
                </div>
                <ul>
                    <li><strong>Risk Stratification:</strong> Identify high-risk families via hereditary screening</li>
                    <li><strong>Early Detection:</strong> Implement liquid biopsy screening programs</li>
                    <li><strong>Epidemiology:</strong> Understanding the unique genetic makeup of Pakistani cancer</li>
                </ul>
            </div>
        </div>
        <div class="impact-stats">
            <div class="impact-card reveal">
                <div class="impact-number">3x</div>
                <div class="impact-label">IMPROVEMENT IN RESPONSE RATES</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">150k</div>
                <div class="impact-label">GENOMIC PROFILES GENERATED</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">30%-40%</div>
                <div class="impact-label">REDUCTION IN INEFFECTIVE SPEND</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">100+</div>
                <div class="impact-label">PROFESSIONALS TRAINED</div>
            </div>
        </div>
        <div class="vision-section">
            <div class="card reveal">
                <h4>National Strategic Goal</h4>
                <div class="vision-items">
                    <div class="vision-item">
                        <span class="vision-icon">üèÜ</span>
                        <div>
                            <h5>Tier-1 Research Institute Status</h5>
                            <p>Capacity Building: Workforce Development, Research Output, Global Collaboration</p>
                        </div>
                    </div>
                    <div class="vision-item">
                        <span class="vision-icon">üåü</span>
                        <div>
                            <h5>Regional Leadership</h5>
                            <p>First large-scale precision oncology hub in South Asia, Medical Tourism, Sovereignty</p>
                        </div>
                    </div>
                    <div class="vision-item">
                        <span class="vision-icon">üéØ</span>
                        <div>
                            <h5>VISION 2030</h5>
                            <p>In Precision Medicine & Genomics - Regional Leader</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="local-manufacturing">
    <div class="container">
        <div class="section-title reveal"><h2>Local Medicine Manufacturing Initiative</h2>
            <p>Building National Biopharma Capacity</p></div>
        <div class="card reveal">
            <h3>Targeted Therapy Production</h3>
            <p>Establish GMP-compliant facilities to manufacture precision oncology drugs locally, reducing reliance on expensive imports.</p>
            <div class="manufacturing-overview">
                <div class="manufacturing-stats">
                    <div class="stat-card reveal">
                        <div class="stat-number">GMP</div>
                        <div class="stat-label">COMPLIANT FACILITIES</div>
                    </div>
                    <div class="stat-card reveal">
                        <div class="stat-number">Local</div>
                        <div class="stat-label">PRODUCTION</div>
                    </div>
                </div>
                <div class="value-chain">
                    <h4>LOCAL VALUE CHAIN CREATION</h4>
                    <div class="chain-steps">
                        <div class="chain-step">
                            <h5>Technology Transfer</h5>
                            <p>Collaborate with global biotech leaders to transfer knowledge, proprietary technologies, and manufacturing processes.</p>
                        </div>
                        <div class="chain-step">
                            <h5>Skilled Workforce</h5>
                            <p>Develop local expertise in biopharmaceutical manufacturing and quality control.</p>
                        </div>
                        <div class="chain-step">
                            <h5>Cost Reduction</h5>
                            <p>Significantly reduce treatment costs through local production and supply chain optimization.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="implementation-timeline">
    <div class="container">
        <div class="section-title reveal"><h2>Implementation Timeline</h2>
            <p>Execution Plan - From Foundation to Scale</p></div>
        <div class="card reveal">
            <h3>10-YEAR STRATEGIC ROADMAP (5 PHASES)</h3>
            <p>Phased Rollout Strategy - Structured approach to ensure infrastructure readiness before scaling genomic operations.</p>
        </div>
        <div class="timeline-phases">
            <div class="phase-card reveal">
                <div class="phase-number">01</div>
                <div class="phase-content">
                    <h4>Foundation & Setup</h4>
                    <p class="phase-duration">3-6 Month</p>
                    <ul>
                        <li>Infrastructure: Site selection, lab design, and renovation</li>
                        <li>Procurement: Ordering sequencers and IT hardware</li>
                        <li>Recruitment: Hiring core team (geneticists, bioinformaticians)</li>
                        <li>SOPs: Finalize clinical workflows and data protocols</li>
                    </ul>
                    <div class="phase-funding">USD 10.0 Million Funds</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">02</div>
                <div class="phase-content">
                    <h4>Capacity Building</h4>
                    <p class="phase-duration">3-6 Months</p>
                    <ul>
                        <li>Training: Overseas fellowship programs for key staff</li>
                        <li>Partnerships: Sign MOUs with international genomic centers</li>
                        <li>System Integration: Precision medicine protocols standardized</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 50 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">03</div>
                <div class="phase-content">
                    <h4>Scaling Operations</h4>
                    <p class="phase-duration">1 Year</p>
                    <ul>
                        <li>Clinical Launch: Open Precision Oncology Clinic to public</li>
                        <li>Ramp Up: Scale to 10,000 genomes/year</li>
                        <li>Impact: Early clinical benefits & paper publications</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 100.0 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">04</div>
                <div class="phase-content">
                    <h4>Full Throttle</h4>
                    <p class="phase-duration">2 Year</p>
                    <ul>
                        <li>Milestone: Complete 100,000 WGS target</li>
                        <li>Deep Analytics: AI-driven discovery of novel variants</li>
                        <li>Database: Launch National Cancer Genomic Atlas</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 40.0 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">05</div>
                <div class="phase-content">
                    <h4>Integration & Legacy</h4>
                    <p class="phase-duration">3 Year</p>
                    <ul>
                        <li>Integration: Precision medicine protocols in all public hospitals</li>
                        <li>Sustainability: Transition to self-sustaining revenue model</li>
                    </ul>
                    <div class="phase-goal">Goal: A fully operational, world-class precision oncology ecosystem by 2028</div>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="team">
    <div class="container">
        <div class="section-title reveal"><h2>Our Team</h2></div>
        <div id="lydiarx-team" class="team-group">
            <div class="team-group-head reveal"><h3>LydiaRX</h3>
                <button class="team-group-toggle" data-team-group-toggle>+</button>
            </div>
            <div class="team-grid">
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="NR"></div>
                        <div>
                            <h4>Najib Rehman</h4>
                            <div class="team-role">CEO. Co-Founder</div>
                        </div>
                    </div>
                    <p class="team-bio">Najib is a 20-year data and analytics veteran in life sciences, with roles spanning big pharma to founding ATMPS Ltd, which launched the first patented blockchain solution for personalized medicine.</p>
                    <p class="team-bio--full">Najib is a 20-year data and analytics veteran in life sciences, with roles spanning big pharma to founding ATMPS Ltd, which launched the first patented blockchain solution for personalized medicine. He focuses on transforming data into commercial value and enabling AI/ML capabilities. A trusted advisor to firms like Pfizer and AZ, Najib also founded the successful German tech consultancy, Kokoro, demonstrating a deep understanding of high-performing teams.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="AR"></div>
                        <div>
                            <h4>Dr Andrew Roddam</h4>
                            <div class="team-role">Advisor</div>
                        </div>
                    </div>
                    <p class="team-bio">Dr. Andrew Roddam: A leader in large-scale data infrastructure and genomics. His experience as CEO of Our Future Health (UK's largest health research programme).</p>
                    <p class="team-bio--full">Dr. Andrew Roddam: A leader in large-scale data infrastructure and genomics. His experience as CEO of Our Future Health (UK's largest health research programme) and Chair of SNOMED International provides essential guidance for building LydiaRx's robust, scalable genetic data architecture.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="SA"></div>
                        <div>
                            <h4>S√ÆnicƒÉ Alboaie, PHD</h4>
                            <div class="team-role">CTO. Co-Founder</div>
                        </div>
                    </div>
                    <p class="team-bio">S√ÆnicƒÉ holds a PhD in Privacy Preserving Technologies and Blockchain and is an experienced entrepreneur, having founded Axiologic Research in 2003.</p>
                    <p class="team-bio--full">S√ÆnicƒÉ holds a PhD in Privacy Preserving Technologies and Blockchain and is an experienced entrepreneur, having founded Axiologic Research in 2003. He is the initiator of OpenDSU (2016), an open-source project utilized in enterprise blockchain solutions for the pharma industry and an ongoing Horizon Europe project focused on Trustworthy AI and research on AI Agents. He has led dozens of projects for his startups and is passionate about AI-assisted research and building automations using AI Agents.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="KF"></div>
                        <div>
                            <h4>Khurem Farooq</h4>
                            <div class="team-role">Advisor</div>
                        </div>
                    </div>
                    <p class="team-bio">Khurem is a senior leader in the pharmaceutical and biotech sector with extensive global experience in bringing pharmacology, biologics and advance therapies from early stage to market.</p>
                    <p class="team-bio--full">Khurem is a senior leader in the pharmaceutical and biotech sector with extensive global experience in bringing pharmacology, biologics and advance therapies from early stage to market. He is currently the CEO of Verdiva Bio.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="DF"></div>
                        <div>
                            <h4>Daud Farooq</h4>
                            <div class="team-role">Legal. Co-Founder</div>
                        </div>
                    </div>
                    <p class="team-bio">Over nineteen years of experience as a Lawyer and thirteen as a Managing Partner in a UK Law Firm. Extensive knowledge of complex commercial transactions including cross border negotiation.</p>
                    <p class="team-bio--full">Over nineteen years of experience as a Lawyer and thirteen as a Managing Partner in a UK Law Firm. Extensive knowledge of complex commercial transactions including cross border negotiation. Working for high profile clients in international dispute resolution involving complex financial and trust arrangements. Negotiated for clients with Governments and Sovereign Funds and has experience in funding arrangements and structuring projects for delivery. Business interests in various countries and a strong presence in Algeria, Pakistan and Turkey.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="SH"></div>
                        <div>
                            <h4>Dr Shahid Hanif</h4>
                            <div class="team-role">Advisor</div>
                        </div>
                    </div>
                    <p class="team-bio">Dr. Shahid Hanif: A strategist focused on Real-World Evidence (RWE) and market access. His leadership at the GetReal Institute and the ABPI (pharma industry).</p>
                    <p class="team-bio--full">Dr. Shahid Hanif: A strategist focused on Real-World Evidence (RWE) and market access. His leadership at the GetReal Institute and the ABPI (pharma industry) is key to guiding LydiaRx on how to use its data to validate technologies, gain regulatory approval, and drive commercial value.</p>
                    <button class="team-toggle">+</button>
                </div>
            </div>
        </div>
        <div id="premium-team" class="team-group">
            <div class="team-group-head reveal"><h3>Premium</h3>
                <button class="team-group-toggle" data-team-group-toggle>+</button>
            </div>
            <div class="team-grid">
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="WK"></div>
                        <div>
                            <h4>Wajahat Khan</h4>
                            <div class="team-role">CEO. Co-Founder</div>
                        </div>
                    </div>
                    <p class="team-bio">Wajahat Khan is the CEO of Precision Omics and Premium Labs, a prominent diagnostic and health complex based in Rawalpindi, Pakistan.</p>
                    <p class="team-bio--full">Wajahat Khan is the CEO of Precision Omics and Premium Labs, a prominent diagnostic and health complex based in Rawalpindi, Pakistan. Which provides advanced medical diagnostic and Radiological Services. He also got award from President of Pakistan against his services to the people of Pakistan during COVID-19 pandemic.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="JH"></div>
                        <div>
                            <h4>Dr Jawad Hasan</h4>
                            <div class="team-role">Consultant Genetics</div>
                        </div>
                    </div>
                    <p class="team-bio">He serves as a Consultant in Medical Genetics at Shifa International Hospital and with a Ph.D. from Quaid-e-Azam University, he specializes in human genetics.</p>
                    <p class="team-bio--full">He serves as a Consultant in Medical Genetics at Shifa International Hospital and with a Ph.D. from Quaid-e-Azam University, he specializes in human genetics, genetic disorders, inherited diseases, and related fields, contributing to clinical practice, research, and public awareness through publications and consultations on topics like congenital conditions and medical genetics testing.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="HA"></div>
                        <div>
                            <h4>Hamid Ali Awan</h4>
                            <div class="team-role">Director Technical</div>
                        </div>
                    </div>
                    <p class="team-bio">With over 18 years of experience at the intersection of genomics, technology, and marketing, Throughout his career, Mr. Hamid has worked with industry-leading molecular biology brands.</p>
                    <p class="team-bio--full">With over 18 years of experience at the intersection of genomics, technology, and marketing, Throughout his career, Mr. Hamid has worked with industry-leading molecular biology brands, including Illumina, Thermo Fisher, Applied Biosystems, and Cepheid. He has played a pivotal role in introducing cutting-edge genomic technologies to clinicians, academics, and researchers, driving advancements in molecular diagnostics and personalized medicine.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="MZ"></div>
                        <div>
                            <h4>Dr Muhammd Zahid</h4>
                            <div class="team-role">Consultant Genetics</div>
                        </div>
                    </div>
                    <p class="team-bio">Dr. Muhammad Zahid is a Pakistani human geneticist and molecular biologist. He holds a PhD in Human/Medical Genetics from Quaid-i-Azam University, Islamabad.</p>
                    <p class="team-bio--full">Dr. Muhammad Zahid is a Pakistani human geneticist and molecular biologist. He holds a PhD in Human/Medical Genetics from Quaid-i-Azam University, Islamabad. He practices as a Geneticist, offering consultations on genetic disorders, prenatal screening, genetic counselling, inherited conditions, rare genetic disorders, and genomic testing. With expertise in NGS (Next-Generation Sequencing) applications and molecular techniques.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="AK"></div>
                        <div>
                            <h4>Ali Khan</h4>
                            <div class="team-role">Legal Advisor</div>
                        </div>
                    </div>
                    <p class="team-bio">Barrister Ali Khan is a prominent Pakistani lawyer, leading law firm in Pakistan specializing in high-value commercial transactions, energy, infrastructure.</p>
                    <p class="team-bio--full">Barrister Ali Khan is a prominent Pakistani lawyer, leading law firm in Pakistan specializing in high-value commercial transactions, energy, infrastructure, public-private partnerships (PPP), and regulatory frameworks. Recognized as a pioneer in Pakistan's PPP sector, with expertise in advising international and local clients on complex projects. His firm has been awarded 'Pakistan Firm of the Year' and is highly regarded for providing end-to-end legal services in different niche sectors.</p>
                    <button class="team-toggle">+</button>
                </div>
                <div class="team-card reveal">
                    <div class="team-header">
                        <div class="team-placeholder" data-initials="AR"></div>
                        <div>
                            <h4>Ms Areej</h4>
                            <div class="team-role">International Relation Officer</div>
                        </div>
                    </div>
                    <p class="team-bio">International Relations Officer supporting global partnerships and collaborations for the Precision Omics initiative.</p>
                    <p class="team-bio--full">International Relations Officer supporting global partnerships and collaborations for the Precision Omics initiative, focusing on establishing international relationships and coordinating with global health organizations and research institutions.</p>
                    <button class="team-toggle">+</button>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="news">
    <div class="container">
        <div class="news-wrap reveal">
            <div class="news-head">
                <div><span class="tag">Call to Action</span>
                    <h3>PARTNERSHIP FOR A HEALTHIER PAKISTAN</h3></div>
                <p>Our Shared Vision</p></div>
            <div class="vision-quote">
                <blockquote>"A future where every Pakistani, regardless of geography or income, receives timely, precise, and world-class cancer care driven by their unique genetic profile."</blockquote>
            </div>
            <div class="news-strip" id="news-strip"><p class="news-empty">Call to Action</p></div>
            <div class="cta-row" style="margin-top: var(--space-3);"><a class="btn btn-ghost" href="news.html">Initiate
                Partnership</a></div>
        </div>
    </div>
</section>
<section id="contact">
    <div class="container split">
        <div class="card reveal"><h3>Contact Us</h3>
            <ul>
                <li>Initiate Partnership</li>
                <li>Precision Omics</li>
                <li>Pioneering Precision Medicine in South Asia</li>
                <li>Wajahat Khan CEO</li>
                <li>info@precisionomicspk.com</li>
                <li>+92 347-7070670</li>
                <li>F7, Islamabad</li>
                <li>Site: site allocation for the infrastructure and Building</li>
                <li>Call to Action</li>
                <li>Partnership for a Healthier Pakistan</li>
            </ul>
        </div>
        <div class="cta reveal"><h3>Government Support Request</h3>
            <p>Key Enablers for Success</p>
            <ul>
                <li>Co-Sponsorship: Official endorsement of the 150,000+ WGS as a National Genome program Initiative
                </li>
                <li>Policy Framework: Establishment of independent Governance &amp; Ethical Board</li>
                <li>Funding: Public-private matching grant for infrastructure setup (Phase 1).</li>
                <li>Ready for Immediate Implementation</li>
            </ul>
            <a class="btn btn-primary" href="mailto:info@precisionomicspk.com">Initiate Partnership</a></div>
    </div>
</section>
<footer>
    <div class="container"><strong>Precision Omics</strong><br/>Pioneering Precision Medicine in South Asia</div>
</footer>
<script src="assets/site.js"></script>
<script src="assets/nav-toggle.js"></script>
</body>
</html>
